Fulvestrant and Bevacizumab in Treating Patients With Metastatic Breast Cancer

This study has been completed.
Sponsor:
Collaborator:
Information provided by:
National Cancer Institute (NCI)
ClinicalTrials.gov Identifier:
NCT00423917
First received: January 16, 2007
Last updated: June 17, 2012
Last verified: January 2009